Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
A
Ankur Varma
Associate Professor
Also affiliated: Rush University Medical Center (2019–2023); The University of Texas MD Anderson Cancer Center (2012–2020); Baylor College of Medicine (2016–2018); Tampa General Hospital (1998); Himalayan Institute of Yoga Science and Philosophy (2002); Coleman Foundation (2020); Winthrop Rockefeller Foundation (2023–2026); Shanghai Cell Therapy Research Institute (2019); University of Houston (2015); Rush University (2019–2023); Institute of Medical Sciences (2010); All India Institute of Medical Sciences (1993–2000); The University of Texas Health Science Center at Houston (2014–2015)
Faculty Researcher
COM | Internal Med Hem-Onc
14 h-index
90 pubs
957 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ankur Varma's research focuses on hematopoietic stem cell transplantation (HSCT) and related hematologic malignancies. His work investigates treatment outcomes and potential complications associated with HSCT, including graft-versus-host disease (GVHD) and infectious complications like human herpesvirus 6 (HHV-6) associated hyponatremia. Varma has explored novel therapeutic approaches, such as the use of anti-CD117 monoclonal antibodies in conditioning regimens for acute myeloid leukemia and myelodysplastic syndrome. He also examines specific patient populations, including older adults and those with myeloproliferative neoplasms in blast phase, aiming to improve survival rates and understand disease progression. His publications include consensus recommendations on managing donor-specific anti-HLA antibodies and reviews on immune effector cell-associated HLH-like syndrome and hyperhemolysis in sickle cell disease. Varma holds an h-index of 14 with 90 publications and 941 citations.
Metrics
- h-index: 14
- Publications: 90
- Citations: 957
Selected Publications
-
In vivo CAR T-cell engineering in B-cell malignancies: A systematic review of emerging clinical and translational evidence. (2026)
-
Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas. (2026)
-
Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS (2026)
-
Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL (2026)
-
Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study (2025)
-
Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025)
-
Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy. (2025)
-
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
-
The Effect of Sickle Cell Disease on Seizure-Related Hospitalizations: An Analysis of the Nationwide Inpatient Sample 2021 (2025)
-
Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025)
-
Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances (2025)
-
Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report (2025)
-
Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting (2024)
-
Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis (2024)
-
Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy (2024)
Grants & Funding
As listed on this researcher's institutional profile.
- MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI myeloMATCH Clinical Trials NIH/Nat. Cancer Institute via SouthWest Oncology Group Principal Investigator
Collaboration Network
Top Collaborators
Mamatha Gaddam
University of Arkansas for Medical Sciences
10 shared publications
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
Showing 5 of 10 shared publications
Cesar Gentille Sanchez
University of Arkansas for Medical Sciences
10 shared publications
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
Showing 5 of 10 shared publications
Nishanth Thalambedu
University of Arkansas for Medical Sciences
8 shared publications
In database
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- HL-697 Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
Showing 5 of 8 shared publications
Muthu Sendhil Kumaran
University of Arkansas for Medical Sciences
8 shared publications
In database
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting
Showing 5 of 8 shared publications
Alan Baltz
University of Arkansas for Medical Sciences
7 shared publications
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
Showing 5 of 7 shared publications
Sruthi Vellanki
Willis-Knighton Cancer Center
7 shared publications
In database
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- HL-697 Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
Showing 5 of 7 shared publications
Bhavesh Mohan Lal
University of Arkansas for Medical Sciences
4 shared publications
In database
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
Anup Kumar Trikannad Ashwini Kumar
University of Arkansas for Medical Sciences
3 shared publications
In database
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
Anup Kumar Trikannad
University of Arkansas for Medical Sciences
3 shared publications
In database
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
Toshali Pandey
University of Arkansas for Medical Sciences
3 shared publications
In database
- Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report
- Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
Zhong‐Ning Chen
University of Arkansas for Medical Sciences (US)
2 shared publications
- HL-697 Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
Tyler Fugere
Winthrop Rockefeller Foundation (US)
1 shared publication
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
Akash Mukherjee
Winthrop Rockefeller Foundation
1 shared publication
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
Muthu Veeraputhiran
University of Arkansas for Medical Sciences
1 shared publication
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
Anup Kumar
University of Arkansas for Medical Sciences
1 shared publication
In database
- HL-697 Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
Similar Researchers
Based on overlapping research topics
Ahmad Mazen Safar
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Immune Response and Inflammation
A Almashayekh
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Gaven K. Smart
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Immune Response and Inflammation
Matthew R. Savage
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Disease Mechanisms Research
Immune Response and Inflammation
Thomas E. Goodwin
Hendrix College
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Immune Response and Inflammation
Sruthi Kanuru
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Immune Response and Inflammation
Retrospective Studies